ArticleCancer medicine2023

Immunotherapy combined with chemotherapy improved clinical outcomes over bevacizumab combined with chemotherapy as first-line therapy in adenocarcinoma patients.

Min Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.